BRIEF-Affimed Reports New Data For AFM13 From Two Separate Clinical Trials By: Reuters: Company News February 01, 2018 at 08:39 AM EST * AFFIMED REPORTS NEW DATA FOR AFM13 FROM TWO SEPARATE CLINICAL TRIALS IN HODGKIN AND CD30-POSITIVE LYMPHOMAS Read More >> Related Stocks: Affimed Ord Shs Merck & Co